Enwave Corporation Stock
Your prediction
Enwave Corporation Stock
Pros and Cons of Enwave Corporation in the next few years
Pros
Cons
Performance of Enwave Corporation vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Enwave Corporation | -5.360% | 0.000% | 0.870% | 57.823% | -1.695% | -15.328% | -73.455% |
| Aurinia Pharmaceuticals Inc. | -4.690% | -5.689% | -10.604% | 58.333% | -8.315% | 68.739% | 9.875% |
| Spectral Medical Inc | -2.350% | -3.409% | 9.677% | 167.296% | 6.918% | 237.302% | 229.457% |
| Fennec Pharmaceuticals Inc. | 1.630% | 0.781% | 2.381% | 19.444% | 0.781% | -29.121% | 0.781% |
News
EnWave Reports 2025 Fourth Quarter and Annual 2025 Consolidated Financial Results
Vancouver, B.C., December 15th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") today reported the Company’s consolidated interim financial results for the fourth
EnWave Signs Royalty-Bearing Commercial License with Shinyway International Limited of New Zealand
Vancouver, B.C., November 12th, 2025 – EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement
EnWave Signs Royalty-Bearing Commercial License with U.S. Snacking Company, Sells 10kW Radiant Energy Vacuum Machinery
Vancouver, B.C., November 10th, 2025 / EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the "Company") announced today that it has signed a royalty-bearing, commercial license agreement

